The purposes of this clinical trial are to test 1. Whether 1-week rifaximin treatment is able to restore the gut microbiota in a long-term manner in people with Parkinson's disease? 2. Whether the restoration of gut microbiota in people with Parkinson's disease is associated with the reduction of systemic inflammation and circulating exosomal α-synuclein?
Modulation of Gut Microbiota by Rifaximin... - Cure Parkinson's
Modulation of Gut Microbiota by Rifaximin in PD Patients
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Dry Mouth, Gum Disease, Chapped Lips, Dry Eyes, Dry Skin, Eye Floaters And Some Possible Help From A Single Spray!
With winter just around the corner, this information may be most useful and timely! With winter...
Methylphenidate (Ritalin) in Long-term Treatment of Parkinson’s
Edit: The paper linked in this post has some questionable aspects. But it does offer...
Dopamine Dysregulation Syndrome
Definition here;
https://en.m.wikipedia.org/wiki/Dopamine_dysregulation_syndrome
How can docs be...
In Pursuit Of Restful Sleep And Help For Nocturia
One topic that seems to come up regularly on this forum is the issue of poor sleep or insomnia and...
If we accept that PD is basically a metabolic dysfunction...then electrolytes
The metabolic dysfunction theory as I understand it, states that the energy production factories...
Adding Sinemet to Mucuna
Carnivore Diet - Can't solidly recommend it
Optimising LD timings
Dr. Greger's view on NAD supplementation
